RVL PHARMACEUTICALS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-99.00% | -99.97% |
| Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
| Mar. 21 | North American Morning Briefing : Investors -2- | DJ |
Chart calendar RVL Pharmaceuticals plc
c00dfe98db.qZnQNdQ_GSWToVD8vabEbGRbNH00OLoTbpvQ82J1UA8.mPWqb_lyK0Dj6T6qiMmpXiIxRxUDU8kmB-OYpTcQBGLkw7Rlpwx9UqvJYA~1a44b105609a34046831f4fd92d4866e
Upcoming events on RVL Pharmaceuticals plc
Past events on RVL Pharmaceuticals plc
| 2024-03-26 | Q4 2023 Earnings Release (Projected) |
| 2023-12-19 11:00 am | Extraordinary Shareholders Meeting |
| 2023-10-01 | Extraordinary Shareholders Meeting |
| 2023-09-12 11:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-14 08:30 am | Q2 2023 Earnings Call |
| 2023-08-14 06:50 am | Q2 2023 Earnings Release |
| 2023-06-15 10:00 am | Annual General Meeting |
| 2023-05-11 08:30 am | Q1 2023 Earnings Call |
| 2023-05-11 06:51 am | Q1 2023 Earnings Release |
| 2023-03-20 08:30 am | Q4 2022 Earnings Call |
| 2023-03-20 06:50 am | Q4 2022 Earnings Release |
| 2022-12-08 09:00 am | Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference |
| 2022-11-10 04:30 pm | Q3 2022 Earnings Call |
| 2022-11-10 04:05 pm | Q3 2022 Earnings Release |
| 2022-09-12 11:00 am | H.C. Wainwright Global Investment Conference |
| 2022-08-11 08:30 am | Interim 2022 Earnings Call |
| 2022-08-11 06:50 am | Interim 2022 Earnings Release |
| 2022-06-16 10:00 am | Annual General Meeting |
| 2022-06-09 01:30 pm | Jefferies Healthcare Conference |
| 2022-05-24 11:00 am | H.C. Wainwright Global Life Sciences Investment Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 264 267 -1.19% | 240 234 2.7% | 178 175 1.91% | 17,5 17,7 -1.25% | 49,7 52,5 -5.32% |
|
EBITDA Million USD | Released Forecast Spread | 95,1 102 -6.34% | 68,8 63,2 8.96% | 40,6 19,3 110.54% | -60,7 -67,3 9.8% | -50,9 -52,7 3.45% |
|
EBIT Million USD | Released Forecast Spread | 13,6 10,2 32.48% | -281 -258 -8.8% | -70,4 -23,6 -198.92% | -82,8 -81,6 -1.39% | -59,0 -48,3 -22.01% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -298 -226 -31.84% | -84,3 -38,2 -120.8% | -82,5 -79,8 -3.39% | -51,7 -48,9 -5.78% |
|
Net income Million USD | Released Forecast Spread | -109 -22,4 -388.58% | -271 -249 -8.99% | -79,6 -38,5 -106.49% | -64,9 -80,3 19.1% | -51,7 -49,1 -5.22% |
|
EPS USD | Released Forecast Spread | -2,42 -1,52 -59.21% | -5,17 -4,68 -10.59% | -1,31 -0,65 -102.32% | -0,96 -0,88 -9.09% | -0,58 -0,55 -6% |
| Announcement Date | 27/03/19 | 18/03/20 | 30/03/21 | 30/03/22 | 20/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 34,8 34,6 0.72% | 2,20 2,36 -6.86% | 2,86 3,10 -7.81% | 21,4 6,80 215.38% | 8,45 8,52 -0.83% | 10,0 10,0 -0.06% | 9,81 12,7 -22.96% | 8,83 9,20 -3.97% | 8,26 10,3 -19.47% |
|
EBITDA Million USD | Released Forecast Spread | -8,35 -1,30 -542.31% | -20,3 -19,6 -3.66% | -15,2 -21,7 29.83% | -18,9 -13,6 -38.66% | -11,8 -17,2 31.66% | -10,9 -15,9 31.36% | -9,32 -12,4 24.84% | -8,66 -9,00 3.83% | |
|
EBIT Million USD | Released Forecast Spread | -12,3 -5,75 -113.88% | -25,2 -20,9 -20.23% | -23,1 -21,5 -7.28% | -5,40 -17,8 69.73% | -15,1 -19,0 20.32% | -13,9 -16,8 17.06% | -24,5 -14,9 -65% | -10,3 -12,1 15.02% | -8,12 -10,5 22.36% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,4 -8,70 -100.23% | -26,0 -21,4 -21.6% | -19,8 -21,9 9.9% | -6,90 -17,6 60.85% | -11,8 -20,2 41.57% | -14,4 -18,6 22.52% | -18,6 -16,9 -10.07% | -11,6 -13,5 14.31% | -24,0 -11,8 -103.29% |
|
Net income Million USD | Released Forecast Spread | -17,7 -8,70 -103.76% | -17,9 -21,5 16.84% | -19,7 -21,9 10.06% | -6,82 -17,6 61.28% | -12,1 -20,2 40.2% | -14,4 -18,6 22.18% | -18,3 -16,9 -8.38% | -11,6 -13,5 13.88% | -23,9 -11,8 -102.33% |
|
EPS USD | Released Forecast Spread | -0,28 -0,14 -100% | -0,28 -0,32 11.11% | -0,24 -0,27 10% | -0,08 -0,21 62.22% | -0,14 -0,21 32.53% | -0,16 -0,16 1.08% | -0,19 -0,17 -13.5% | -0,12 -0,12 -0.5% | -0,24 -0,12 -101.68% |
| Announcement Date | 16/08/21 | 15/11/21 | 30/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 20/03/23 | 11/05/23 | 14/08/23 |
More events
Past sector events for RVL Pharmaceuticals plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RVLPQ Stock
- Calendar RVL Pharmaceuticals plc
